Therapeutic Benefit of Bortezomib on Acute Graft-Versus-Host Disease Is Tissue Specific and Is Associated With Interleukin-6 Levels

Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2014.07.022
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Identification and Validation of Biomarkers Associated With Acute and Chronic Graft Versus Host Disease

Bone Marrow Transplantation
TransplantationHematology
2015English

APRIL Levels Are Associated With Disease Activity in Human Chronic Graft-Versus-Host Disease

Haematologica
Hematology
2016English

Pretransplant Β 2 -Microglobulin Is Associated With the Risk of Acute Graft-Versus-Host-Disease After Allogeneic Hematopoietic Cell Transplant

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Severity of Acute Gastrointestinal Graft‐Versus‐Host Disease Is Associated With Incidence of Bloodstream Infection After Adult Allogeneic Hematopoietic Stem Cell Transplantation

Transplant Infectious Disease
Infectious DiseasesTransplantation
2019English

PRMT5 Regulates T Cell Interferon Response and Is a Target for Acute Graft-Versus-Host Disease

JCI insight
Medicine
2020English

Acute Graft Versus Host Disease: A Brief Review

Turkish Journal of Haematology
Hematology
2019English

Pre-Transplant and Peri-D100 Gastrointestinal Dysbiosis Is Associated With the Subsequent Development of Chronic Graft-Versus-Host Disease

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Soluble Interleukin-27 Receptor Alpha Is a Valuable Prognostic Biomarker for Acute Graft-Versus-Host Disease After Allogeneic Haematopoietic Stem Cell Transplantation

Scientific Reports
Multidisciplinary
2018English

Acute Graft-Versus-Host Disease: Inflammation Run Amok?

Journal of Clinical Investigation
Medicine
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy